PR isoform ratio is a prognostic and predictive factor for responsiveness of breast tumors to PR antagonists and PR antagonists inhibit growth of breast tumors expressing higher levels of PRA [17, 44, 55]. This evidence concerns the gene PGR and breast neoplasm.